ARAP1-AS2

Across TCGA pan-cancer cohorts, ARAP1-AS2 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of ARAP1-AS2’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ARAP1-AS2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ARAP1-AS2 is over-expressed in tumor.

KIRC, KICH, and LIHC are the cancer types where ARAP1-AS2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ARAP1-AS2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.310	<.001	11	view →
KICH	Male	II,III,IV	+0.926	<.001	7	view →
LIHC	All	All	+0.082	<.001	7	view →
STAD	All	II,III,IV	+0.438	<.001	6	view →
COAD	All	All	+0.188	<.001	6	view →
HNSC	All	All	+0.079	.001	5	view →
BLCA	All	III,IV	+0.288	.028	3	view →
CHOL	All	All	+0.555	.012	1	view →
THCA	All	All	+0.116	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

ARAP1-AS2–KIRC

Open the KIRC breakdown →